Abstract: The present invention is concerned with a method of rapid identification of a mammalian species origin or mammalian species origins of a sample.

Abstract: The present invention is concerned with a method of rapid identification of a mammalian species origin or mammalian species origins of a sample.

Abstract: This invention relates to a method of screening agents for cardiotoxicity based on the observations of the alteration of heart rate and heart rhythm, using teleost embryos and larvae. This invention also relates to a method for identification of gene(s) related to cardiac functions in teleost.

Abstract: This invention relates to a method of 3-tier system for screening compounds, herb extract or extract of herb combination in formula with angiogenic-modulating activities using transparent teleost embryos as model.

Abstract: The present invention relates to a transgenic fish having at least one genomically integrated expression cassette containing a 5?-regulatory nucleotide sequence responsive to hormones, particularly estrogenic hormones, connected in a functional manner upstream of a nucleotide sequence encoding a reporter protein. The present invention further relates to methods of using the transgenic fish for various purposes, including, for example: (1) identifying estrogenic endocrine disruptors; (2) monitoring estrogen-like activity of test samples; (3) identifying anti-estrogenic endocrine disruptors; and (4) investigating the effects of endocrine disruptors on liver regeneration. Expression cassettes, host cells, and transgenic cells of aquatic animals are also disclosed.

Abstract: There is provided a method of rapid identification of a mammalian species origin or mammalian species origins of a sample. The method includes but not limited to the steps of 1) gathering a sample to be tested, 2) processing the sample for use for identification purpose, 3) dividing the sample into a number of portions for situation in a multi-well container or containers, 4) providing a plurality of DNA probes, at least some of the DNA probes having DNA sequences with SEQ ID NOs. 1-241, wherein the number of the sample portions is greater than the number of mammalian species types from which the DNA probes derives.

Abstract: The present invention relates to a transgenic fish having at least one genomically integrated expression cassette containing a 5?-regulatory nucleotide sequence responsive to hormones, particularly estrogenic hormones, connected in a functional manner upstream of a nucleotide sequence encoding a reporter protein. The present invention further relates to methods of using the transgenic fish for various purposes, including, for example: (1) identifying estrogenic endocrine disruptors; (2) monitoring estrogen-like activity of test samples; (3) identifying anti-estrogenic endocrine disruptors; and (4) investigating the effects of endocrine disruptors on liver regeneration. Expression cassettes, host cells, and transgenic cells of aquatic animals are also disclosed.

Abstract: The present invention relates to a transgenic fish having at least one genomically integrated expression cassette containing a 5?-regulatory nucleotide sequence responsive to hormones, particularly estrogenic hormones, connected in a functional manner upstream of a nucleotide sequence encoding a reporter protein. The present invention further relates to methods of using the transgenic fish for various purposes, including, for example: (1) identifying estrogenic endocrine disruptors; (2) monitoring estrogen-like activity of test samples; (3) identifying anti-estrogenic endocrine disruptors; and (4) investigating the effects of endocrine disruptors on liver regeneration. Expression cassettes, host cells, and transgenic cells of aquatic animals are also disclosed.

Abstract: This invention relates to a method of screening agents for cardiotoxicity based on the observations of the alteration of heart rate and heart rhythm, using teleost embryos and larvae. This invention also relates to a method for identification of gene(s) related to cardiac functions in teleost.

Abstract: This invention relates to a method of 3-tier system for screening compounds, herb extract or extract of herb combination in formula with angiogenic-modulating activities using transparent teleost embryos as model.